SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001493152-21-012287
Filing Date
2021-05-20
Accepted
2021-05-19 17:39:37
Documents
3

Document Format Files

Seq Description Document Type Size
1 formsc13da.htm SC 13D/A 78579
2 ex4.htm EX-4 25912
3 ex5.htm EX-5 26187
  Complete submission text file 0001493152-21-012287.txt   132584
Mailing Address MORRIS CORPORATE CENTER 1, BUILDING C, 300 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER 1, BUILDING C, 300 INTERPACE PARKWAY PARSIPPANY NJ 07054 412-224-6100
INTERPACE BIOSCIENCES, INC. (Subject) CIK: 0001054102 (see all company filings)

IRS No.: 222919486 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-57799 | Film No.: 21941460
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 2929 WALNUT STREET SUITE 1240 PHILADELPHIA PA 19104
Business Address 2929 WALNUT STREET SUITE 1240 PHILADELPHIA PA 19104 215-662-1315
1315 Capital II, L.P. (Filed by) CIK: 0001730825 (see all company filings)

IRS No.: 823699113 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A